focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

Edison issues review on Tetragon Financial Group (TFG): FY23 growth driven by idiosyncratic factors

16 Apr 2024 12:07

Edison Investment Research Limited Edison issues review on Tetragon Financial Group (TFG): FY23 growth driven by idiosyncratic factors 16-Apr-2024 / 12:07 GMT/BST The issuer is solely responsible for the content of this announcement.


 

London, UK, 16 April 2024

Edison issues review on Tetragon Financial Group (TFG): FY23 growth driven by idiosyncratic factors

Tetragon Financial Group (Tetragon) posted a 6.4% net asset value (NAV) per share total return in US dollar terms in FY23. Tetragon’s returns normally have a low correlation with broader markets, and therefore its FY23 performance was below the 26.3% return of the S&P 500 Index, which rallied on the artificial intelligence (AI) theme. Tetragon’s FY23 return on equity of 5.5% was below its target of 10–15% pa. That said, its performance since listing was within the target range at 11.3%. Tetragon continues payouts to its shareholders, distributing US$83.6m in FY23 through buybacks and dividends (3.0% of opening NAV), with the dividend yield standing at 4.4%.

Tetragon’s performance in 2023 was primarily driven by idiosyncratic developments in portfolio companies – favourable rulings in the Ripple case, good operational developments in one of its Australian gold projects, one biotech company reporting encouraging developments for its potential cancer and autoimmune therapies, as well as exposure to companies positioned to benefit from AI infrastructure demand. After six consecutive years of TFG Asset Management being the main driver of growth (see chart above), its valuation remained broadly flat in 2023 (0.2pp contribution to NAV), while Tetragon’s portfolio of listed equities contributed 4.5pp in growth (from biotech and AI) and private equity exposure added a further 3.3pp (from Ripple Labs and the above-mentioned gold project).

Click here to view the full report.

All reports published by Edison are available to download free of charge from its website

www.edisongroup.com

About Edison: As a content-led investor-relations business, Edison helps companies stand out and meet the right shareholders. Edison’s integrated investor relations solution combines expert analyst content, digital targeting and active investor engagement. This drives liquidity and valuations by building bigger, better informed and more engaged investor audiences globally.

Edison has a proven history of increasing liquidity and valuations for its clients. Edison’s content can be viewed by all investors, anywhere in the world.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison’s reports are not solicitations to buy or sell any securities.

For more information, please contact Edison:

Milosz Papst +44 (0)20 3077 5700 investmenttrusts@edisongroup.com

Michal Mordel +44 (0)20 3077 5700 investmenttrusts@edisongroup.com

Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn https://www.linkedin.com/company/edison-group-/

X  www.twitter.com/Edison_Inv_Res

YouTube http://www.youtube.com/edisonitv


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

1881711 16-Apr-2024 

corporate announcement transmitted by EQS Group AG. The issuer is solely responsible for the content of this announcement.

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.